RETROPHIN Trademark

Trademark Overview


On Friday, February 15, 2019, a trademark application was filed for RETROPHIN with the United States Patent and Trademark Office. The USPTO has given the RETROPHIN trademark a serial number of 88304123. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 8, 2021. This trademark is owned by Retrophin, Inc.. The RETROPHIN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals for the treatment of rare diseases; research and development for the treatment of hypertension, kidney stones, gallstones, cholesterol, rage disorders, lactation, schizophrenia, autism, kidney disease, neurodegeneration, infantile spasms, nephrotic syndrome, muscular dystrophy, and diabetic nephropathy
retrophin

General Information


Serial Number88304123
Word MarkRETROPHIN
Filing DateFriday, February 15, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 10, 2019

Trademark Statements


Indication of Colors claimedThe color(s) blue, green, white and black is/are claimed as a feature of the mark.
Description of MarkThe mark consists of a white pathway through a center of a circle, the pathway dividing individual triangles in varying shades of blue on the left side of the pathway and varying shades of blue and green on the right side of the pathway, centered above the word "RETROPHIN" in black.
Goods and ServicesResearch and development of pharmaceuticals for the treatment of rare diseases; research and development for the treatment of hypertension, kidney stones, gallstones, cholesterol, rage disorders, lactation, schizophrenia, autism, kidney disease, neurodegeneration, infantile spasms, nephrotic syndrome, muscular dystrophy, and diabetic nephropathy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, March 9, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTRAVERE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130

Party NameRetrophin, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameRetrophin, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Monday, March 8, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 8, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 23, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 17, 2020EXTENSION 1 GRANTED
Friday, July 17, 2020EXTENSION 1 FILED
Friday, July 17, 2020TEAS EXTENSION RECEIVED
Tuesday, February 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 4, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 1, 2019ASSIGNED TO LIE
Saturday, October 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 23, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 29, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, April 29, 2019PRIORITY ACTION E-MAILED
Monday, April 29, 2019PRIORITY ACTION WRITTEN
Friday, April 26, 2019ASSIGNED TO EXAMINER
Thursday, March 21, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, March 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 19, 2019NEW APPLICATION ENTERED IN TRAM